Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$403M |
| 2 |
Apple
AAPL
|
+$376M |
| 3 |
Tesla
TSLA
|
+$320M |
| 4 |
Amazon
AMZN
|
+$301M |
| 5 |
Johnson & Johnson
JNJ
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$469M |
| 2 |
Thomson Reuters
TRI
|
+$127M |
| 3 |
Chevron
CVX
|
+$93.7M |
| 4 |
SJR
Shaw Communications Inc.
SJR
|
+$67.2M |
| 5 |
iShares MSCI India ETF
INDA
|
+$52.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.75% |
| 2 | Healthcare | 13.35% |
| 3 | Financials | 11.75% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
ADMA Biologics
ADMA
$2.22B
| $596K | ﹤0.01% |
161,643
+84,565
| +110% | +$313K |
|
|
OLO
2402
DELISTED
Olo Inc
OLO
| $594K | ﹤0.01% |
92,019
+42,635
| +86% | +$307K |
|
|
EFXT
2403
Enerflex
EFXT
$2.44B
| $593K | ﹤0.01% |
87,063
+61,595
| +242% | +$375K |
|
2404
Theravance Biopharma
TBPH
$877M
| $592K | ﹤0.01% |
57,196
+401
| +0.7% | +$4.43K |
|
2405
Smith & Wesson
SWBI
$637M
| $589K | ﹤0.01% |
45,196
+23,064
| +104% | +$281K |
|
|
BBUC
2406
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.04B
| $589K | ﹤0.01% |
31,193
+28,097
| +908% | +$564K |
|
2407
Enact Holdings
ACT
$6.73B
| $588K | ﹤0.01% |
23,383
+10,431
| +81% | +$254K |
|
|
DAWN
2408
DELISTED
Day One Biopharmaceuticals
DAWN
| $586K | ﹤0.01% |
49,100
+46,515
| +1,799% | +$608K |
|
2409
Planet Labs
PL
$8.53B
| $585K | ﹤0.01% |
181,612
+81,495
| +81% | +$323K |
|
|
YSG
2410
Yatsen Holding
YSG
$319M
| $585K | ﹤0.01% |
115,799
| – | – |
|
2411
Revolve Group
RVLV
$1.73B
| $585K | ﹤0.01% |
35,648
+14,654
| +70% | +$273K |
|
2412
Arcturus Therapeutics
ARCT
$211M
| $584K | ﹤0.01% |
20,360
+10,500
| +106% | +$286K |
|
|
BRSL
2413
Brightstar Lottery PLC
BRSL
$2.03B
| $582K | ﹤0.01% |
18,256
-40,269
| -69% | -$1.12M |
|
|
INBX
2414
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $582K | ﹤0.01% |
22,423
+10,546
| +89% | +$246K |
|
2415
Millicom
TIGO
$16.3B
| $578K | ﹤0.01% |
37,946
+20,929
| +123% | +$372K |
|
|
IAS
2416
DELISTED
Integral Ad Science
IAS
| $577K | ﹤0.01% |
32,107
+28,013
| +684% | +$473K |
|
|
DX
2417
Dynex Capital
DX
$3.21B
| $577K | ﹤0.01% |
45,816
+15,407
| +51% | +$180K |
|
2418
Anavex Life Sciences
AVXL
$310M
| $574K | ﹤0.01% |
70,646
+32,706
| +86% | +$280K |
|
2419
Editas Medicine
EDIT
$442M
| $573K | ﹤0.01% |
69,563
-100,558
| -59% | -$876K |
|
2420
Gray Television
GTN
$552M
| $569K | ﹤0.01% |
72,267
-750
| -1% | -$5.77K |
|
|
ZYXI
2421
DELISTED
Zynex
ZYXI
| $569K | ﹤0.01% |
59,376
+8,373
| +16% | +$86.9K |
|
2422
Kura Oncology
KURA
$850M
| $568K | ﹤0.01% |
53,709
+19,538
| +57% | +$231K |
|
2423
Alkami Technology
ALKT
$2.11B
| $567K | ﹤0.01% |
34,566
+25,175
| +268% | +$347K |
|
2424
Hackett Group
HCKT
$287M
| $566K | ﹤0.01% |
25,304
+14,412
| +132% | +$282K |
|
|
MRUS
2425
DELISTED
Merus
MRUS
| $564K | ﹤0.01% |
21,414
+12,898
| +151% | +$282K |
|
Similar funds
Legal & General Group's Q2 2023 Portfolio in Review
As of Q2 2023, Legal & General Group held 3,624 positions worth $307B, up 9.9% from $280B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Legal & General Group's Q2 2023 filing shows 248 new, 1,958 increased, 995 reduced and 215 closed positions. Its largest new stake was Eos Energy Enterprises: 8,222,102 shares worth $35.7M. The largest sale was Canadian Pacific Kansas City, an estimated $469M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Legal & General Group's largest Q2 2023 buy was Eos Energy Enterprises: 8,222,102 shares worth $35.7M.
- Legal & General Group added most to Microsoft in Q2 2023, an estimated $403M increase.
- Legal & General Group's biggest Q2 2023 reduction was Thomson Reuters, cutting an estimated $127M.
- Legal & General Group fully exited Canadian Pacific Kansas City in Q2 2023, selling an estimated $469M.
- Legal & General Group's ten largest holdings make up 26% of its $307B portfolio in Q2 2023.
- Legal & General Group opened 248 new positions and closed 215 in Q2 2023.
- Legal & General Group's portfolio value rose 9.9% quarter-over-quarter to $307B.
Based on Legal & General Group's 13F filing for Q2 2023, filed 14 Aug 2023.